Search Results 181-190 of 18021 for Parkinson's disease

  1. Biperiden (oral route) - Mayo Clinic

    Biperiden is used alone or together with other medicines (e.g., levodopa) to treat Parkinson's disease. By improving muscle control and reducing stiffness ...

  2. Publications - James H. Bower, M.D. - Mayo Clinic

    Krzyzanowski B, Mullan AF, Dorsey ER, Chirag SS, Turcano P, Camerucci E, Bower JH, Savica R. Proximity to Golf Courses and Risk of Parkinson Disease.

  3. A Global Study to Assess the Drug Dynamics, Efficacy, and Safety of GZ/SAR402671 in Parkinson's Disease Patients Carrying a Glucocerebrosidase (GBA) Gene Mutation - Mayo Clinic

    - To assess the exposure of GZ/SAR402671 in cerebrospinal fluid (CSF) when administered in early-stage Parkinson's disease patients carrying a GBA mutation.

  4. A Study to Investigate Biomarkers for Phenotyping of Neurodegenerative Disorders - Mayo Clinic

    ... disorders such as Parkinson's disease (PD), Parkinson's disease dementia and dementia with Lewy bodies (PDD/DLB), multiple system atrophy (MSA), progressive ...

  5. Dr. J. Eric Ahlskog on Parkinson's Disease - Mayo Clinic News Network

    This Medical Edge Weekend program features Mayo Clinic physician Dr. J. Eric Ahlskog on Parkinson's disease. Medical Edge Weekend 6-19-10.

  6. Genetic Evidence that New Therapies Targeting Parkinson's Disease may Cause Harm

    SAN DIEGO — NorthShore University HealthSystem (NorthShore) and Mayo Clinic researchers have partnered on a study that shows genetic and clinical evidence ...

  7. Eye twitching Causes - Mayo Clinic

    ... Parkinson's disease. Very rarely, eye twitching may be a sign of certain brain and nervous system disorders. In these cases, it's almost always accompanied ...

  8. A Study to Evaluate the Effectiveness, Safety, and Tolerability of NLY01 in Early-stage Parkinson's Disease - Mayo Clinic

    The purpose of this study is to assess the safety, tolerability, and effectiveness of NLY01 in subjects with early untreated Parkinson's Disease (PD) and ...

  9. A Phase 3 Study to Examine the Effectiveness, Safety and Tolerability of APL-130277 for the Acute Treatment of Motor Fluctuation Episodes in Patients with Parkinson's Disease - Mayo Clinic

    ... Parkinson's disease. Participation eligibility. Participant eligibility ... Participant eligibility includes age, gender, type and stage of disease, and previous ...

  10. Dr. Eric Ahlskog on Parkinson's Disease - Mayo Clinic News Network

    This Mayo Clinic Medical Edge Weekend episode is a "best of" with Dr. Eric Ahlskog talking about Parkinson's Disease. ... To watch a video of Dr. Ahlskog talking ...